Abstract
Chronic endometritis is one of the most urgent problems of modern gynecology. The difficulties of verification, the lack of unity in the understanding of the nature of the inflammatory lesions of the endometrium, a symptomically uneven picture with multiple negative outcomes for reproduction - all this determines the interest in the pathogenesis, diagnosis and treatment of chronic endometritis. The treatment of endometritis, as a form of inflammatory diseases of the pelvic organs, lies in the use of antibiotic therapy. However, the formation of chronic inflammation is associated not so much with the virulence of the organism, but with the features of the immune response of host and the local immunity of the endometrium. This justifies the use in the treatment of immunomodulatory drugs and drugs with proteolytic action, aimed at preventing fibrosis and sclerosis of tissues. One of these drugs is bovhyaluronidase azoximer (Longidaze).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
